Entia Biosciences (ERGO) 10-Q 14 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 13, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Entia Biosciences, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		28,311,397
Amendment Flag	false
Entity Central Index Key	1,408,299
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2

CONSOLIDATED BALANCE SHEETS (Un

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash	$ 182,029	$ 99,462
Accounts receivable, net	48,043	243,782
Inventory, net	123,687	95,376
Prepaid expenses	20,797	46,107
Total Current Assets	374,556	484,727
Property and Equipment, net	38,779	43,147
Patents and license, net	345,065	342,834
Total Assets	758,400	870,708
Current Liabilities:
Accounts payable and accrued expenses	674,286	569,169
Short-term convertible notes payable, net of discount related-party	12,760	9,399
Short-term convertible notes payable, net of discount	144,722	357,646
Notes payable	8,962	51,030
Total Current Liabilities	840,730	987,244
Total Liabilities	840,730	987,244
Stockholders' Equity (Deficit):
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Series A preferred stock, 350,000 shares designated, 192,807 and 200,807 shares issued and outstanding, respectively, aggregate liquidation value of $964,035 and $1,004,035 respectively	193	201
Common stock, $0.001 par value, 150,000,000 shares authorized, 27,473,897 and 15,512,927 shares issued and outstanding, respectively	27,474	15,514
Additional paid-in capital	12,370,275	10,771,035
Deferred compensation	(73,486)	(86,344)
Accumulated deficit	(12,406,786)	(10,816,942)
Total Stockholders' Equity (Deficit)	(82,330)	(116,536)
Total Liabilities and Stockholders' Equity (Deficit)	$ 758,400	$ 870,708

CONSOLIDATED BALANCE SHEETS (U3

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	27,473,897	15,512,927
Common stock, shares outstanding	27,473,897	15,512,927
Series A Preferred Stock [Member]
Preferred stock, shares authorized	350,000	350,000
Preferred stock, shares issued	192,807	200,807
Preferred stock, shares outstanding	192,807	200,807
Preferred stock, aggregate liquidation value (in Dollars)	$ 964,035	$ 1,004,035

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
REVENUES	$ 108,136	$ 104,693	$ 210,465	$ 267,261
COST OF GOODS SOLD	46,723	36,202	78,348	96,024
GROSS PROFIT	61,413	68,491	132,117	171,237
OPERATING EXPENSES
Advertising and promotion	44,564	13,136	78,234	35,086
Professional fees	46,657	38,454	100,011	87,216
Consulting fees	299,639	191,063	363,474	293,592
General and administrative	620,924	342,938	1,001,581	717,148
Total Operating Expenses	1,011,784	585,591	1,543,300	1,133,042
LOSS FROM OPERATIONS	(950,371)	(517,100)	(1,411,183)	(961,805)
OTHER INCOME (EXPENSES)
Interest expense	(60,248)	(96,684)	(157,509)	(174,402)
Other income (expense)	(26,217)	0	11,348	(12,965)
Loss on settlement of notes payable	(32,500)	0	(32,500)	0
Gain on settlement of accounts payable	0	103,021	0	103,021
NET LOSS	$ (1,069,336)	$ (510,763)	$ (1,589,844)	$ (1,046,151)
NET LOSS PER COMMON SHARE - BASIC AND DILUTED: (in Dollars per share)	$ (0.05)	$ (0.06)	$ (0.08)	$ (0.12)
Weighted common shares outstanding - basic and diluted (in Shares)	23,319,184	8,532,935	19,814,557	8,429,958

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - 6 months ended Jun. 30, 2015 - USD ($)	Preferred Stock [Member]Convertble Preferred Shares [Member]	Preferred Stock [Member]	Common Stock [Member]Convertble Preferred Shares [Member]	Common Stock [Member]Conversion of Convertible Debt [Member]	Common Stock [Member]Conversion of Accounts Payable [Member]	Common Stock [Member]Conversion of Warrants [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]Warrants Issued for Convertible Notes [Member]	Additional Paid-in Capital [Member]Convertble Preferred Shares [Member]	Additional Paid-in Capital [Member]Conversion of Convertible Debt [Member]	Additional Paid-in Capital [Member]Conversion of Accounts Payable [Member]	Additional Paid-in Capital [Member]Conversion of Warrants [Member]	Additional Paid-in Capital [Member]Warrants Issued for Services [Member]	Additional Paid-in Capital [Member]Warrants Issued for Sales Agreement [Member]	Additional Paid-in Capital [Member]	Deferred Compensation, Share-based Payments [Member]Warrants Issued for Services [Member]	Deferred Compensation, Share-based Payments [Member]	Stock Subscriptions [Member]	Retained Earnings [Member]Warrants Issued for Convertible Notes [Member]	Retained Earnings [Member]Conversion of Convertible Debt [Member]	Retained Earnings [Member]Conversion of Accounts Payable [Member]	Retained Earnings [Member]Warrants Issued for Sales Agreement [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2014		$ 201					$ 15,514								$ 10,771,035		$ (86,344)	$ (10,816,942)					$ (116,536)	$ (116,536)
Balance (in Shares) at Dec. 31, 2014		200,807					15,512,927
Issuance of stock for cash								$ 6,850					$ 36,597	$ 7,891		$ (36,597)			$ 6,850			$ 7,891
Amortization of deferred compensation																	80,747						80,747
Net loss																		(1,589,844)					(1,589,844)	(1,589,844)
Issuance of common stock for cash							$ 4,780								515,225								520,005
Issuance of common stock for cash (in Shares)							4,780,000
Issuance of common stock for conversion of securities	$ (8)		$ 80	$ 2,746	$ 360	$ 2,051			$ (72)	$ 286,454	$ 107,472	$ (2,051)								$ 289,200	$ 107,832
Issuance of common stock for conversion of securities (in Shares)	(8,000)		80,000	2,746,382	360,665	2,050,923
Stock compensation							$ 1,550								520,679								522,229
Stock compensation (in Shares)							1,550,000
Issuance of common stock for services							$ 393								88,903								89,296
Issuance of common stock for services (in Shares)							393,000
Balance at Jun. 30, 2015		$ 193					$ 27,474								$ 12,370,275		$ (73,486)	$ (12,406,786)					$ (82,330)	$ (82,330)
Balance (in Shares) at Jun. 30, 2015		192,807					27,473,897

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,589,844)	$ (1,046,151)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation/amortization	17,509	19,710
Gain on settlement of accounts payable	0	(103,021)
Loss on write-off of debt discount	23,321	0
Amortization of discount on convertible notes	106,287	254,202
Stock-based compensation	700,163	388,541
Loss on sale of stock subscription receivable	0	12,965
Changes in operating assets and liabilities:
Accounts receivable	195,739	(19,573)
Inventory	(28,311)	25,875
Prepaid expenses	28,337	15,090
Other current assets	0	(1,300)
Accounts payable and accrued expenses	236,328	196,224
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	(310,471)	(257,438)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(6,399)	(2,654)
Acquisition of patents and patents pending (net)	(8,973)	(7,341)
NET CASH USED IN INVESTING ACTIVITIES	(15,372)	(9,995)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	520,005	0
Proceeds from convertible notes payable and notes payable	50,000	267,000
Payment on notes payable	(161,595)	(20,969)
Payment on convertible note payable - related party	0	(40,000)
Proceeds from sale of stock subscription receivable	0	40,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	408,410	246,031
NET CHANGE IN CASH	82,567	(21,402)
Cash at beginning of period	99,462	36,886
Cash at end of period	182,029	15,484
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	36,032	840
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Warrants issues for services	26,269	0
Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Stock Issued	397,032	83,421
Stock Issued for Services Rendered [Member]
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Stock Issued	89,296	39,556
Stock Issued for Future Services [Member]
SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:
Stock Issued	$ 0	$ 44,250

NOTE 1 - ORGANIZATION AND OPERA

NOTE 1 - ORGANIZATION AND OPERATIONS	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 – ORGANIZATION AND OPERATIONS Entia Biosciences, Inc. (“Entia” or “We”) engage in the distribution of organic dietary supplement nutraceutical products in the United States of America. We are also engaged in the discovery, scientific evaluation and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics and other products developed and sold by Entia and third parties.

NOTE 2 - SUMMARY OF SIGNIFICANT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and principles of consolidation Use of estimates Cash Accounts receivable Inventory Property and equipment Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement Patents Impairment of long-lived assets Discount on convertible notes payable Fair value of financial instruments Fair value measurements Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions. Revenue recognition We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured. Shipping and handling costs Advertising and promotion costs Equity instruments issued to parties other than employees for acquiring goods or services The assumptions used to determine the fair value of our warrants are as follows: - The expected life of warrants issued represents the period of time the warrants are expected to be outstanding. - The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant. - The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant. - The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant. Income taxes Net loss per common share For the Three Months Ended June 30, For the Six Months Ended June 30, 2015 2014 2015 2014 Numerator: Net loss $ (1,069,336 ) $ (510,763 ) $ (1,589,844 ) $ (1,046,151 ) Denominator: Weighted-average common shares outstanding 23,319,184 8,532,935 19,814,557 8,429,958 Basic and diluted net loss per share $ (0.05 ) $ (0.06 ) $ (0.08 ) $ (0.12 ) Common stock warrants 17,791,007 4,520,308 17,791,007 4,520,308 Series A convertible preferred stock 1,928,070 2,378,070 1,928,070 2,378,070 Stock options 2,896,470 2,572,099 2,896,470 2,572,099 Convertible debt including interest 95,438 900,321 95,438 900,321 Excluded dilutive securities 22,710,985 10,370,798 22,710,985 10,370,798 Reclassifications Segments Recently issued accounting pronouncements

NOTE 3 - INVENTORY

NOTE 3 - INVENTORY	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 3 – INVENTORY Inventory consists of the following at: June 30, 2015 December 31, 2014 Raw materials $ 36,932 $ 202,591 Finished goods 237,819 43,849 274,751 246,440 Less: reserve for excess and obsolete inventory (151,064 ) (151,064 ) $ 123,687 $ 95,376

NOTE 4 - PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4 – PROPERTY AND EQUIPMENT June 30, 2015 December 31, 2014 Office equipment $ 30,006 $ 27,507 Production equipment 90,899 86,999 Leasehold improvements 16,328 16,328 137,233 130,834 Less: accumulated depreciation (98,454 ) (87,687 ) $ 38,779 $ 43,147

NOTE 5 - PATENTS AND LICENSES,

NOTE 5 - PATENTS AND LICENSES, NET	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 5 – PATENTS AND LICENSES, NET June 30, 2015 December 31, 2014 Licenses and amortizable patents $ 207,244 $ 207,244 Unamortized patents 175,130 166,159 Accumulated amortization (37,309 ) (30,569 ) Patents and Licenses, net $ 345,065 $ 342,834

NOTE 6 - ACCRUED EXPENSES

NOTE 6 - ACCRUED EXPENSES	6 Months Ended
	Jun. 30, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 6 – ACCRUED EXPENSES Accrued expenses (included with accounts payable) consists of the following at: June 30, 2015 December 31, 2014 Executive compensation $ 320,522 $ 153,432 Other accruals 45,951 19,725 $ 366,473 $ 173,157

NOTE 7 - NOTES PAYABLE

NOTE 7 - NOTES PAYABLE	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 7 – NOTES PAYABLE Notes payable consists of the following: June 30, 2015 December 31, 2014 Notes payable - current 7.85% unsecured, $473 due monthly $ - $ 2,304 7.85% unsecured, $314 due monthly 2,125 - 4.15% unsecured, $3,436 due monthly 6,837 23,726 10.00% unsecured, interest only, due on demand. Note was settled on May 29, 2015 in exchange for 250,000 shares of common stock. In addition, 500,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. We calculated and posted a loss on the settlement in the amount of $32,500. - 25,000 $ 8,962 $ 51,030 Convertible notes payable, net 8% secured due on December 26, 2015 (net of discount related to beneficial conversion feature of $3,521 in 2015 and $7,746 in 2014), convertible into preferred stock at $5.00 per share. $ 46,479 $ 42,254 6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000 50,000 10% unsecured due March 2015 (net of discount related to warrants of $0 in 2015 and $2,362 in 2014). Note and accrued interest were converted on May 7, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 22,638 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $9,800 in 2014). Note and accrued interest were converted on April 30, 2015 for 1,100,000 shares of common stock. In addition, 2,200,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 90,200 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $1,377 in 2014). Paid in full in April 2015. - 8,623 8% unsecured due April 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $11,968 in 2014), This note was converted into 527,911 shares of common stock during first quarter 2015 - 30,532 8% unsecured due May 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $19,190 in 2014), $25,000 of this note was converted into 318,471 shares of common stock while the remaining $28,000 was repaid in cash during first quarter 2015. - 33,810 10% unsecured due December 2015 (net of discount related to warrants of $660 and $4,620 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 29,340 25,380 10% unsecured due December 2015 (net of discount related to warrants of $432 in 2015 and $1,727 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 9,568 8,273 10% unsecured due October 2015 (net of discount related to warrants of $665 in 2015 and $1,805 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 9,335 8,195 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $4,512 in 2014) Note and accrued interest were converted on May 21, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 20,488 8% unsecured due September 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $36,247 in 2014). This note was paid off during quarter ended June 30, 2015 - 17,253 $ 144,722 $ 357,646 Convertible notes payable, net related party 0% unsecured due November 2015 (net of discount related to beneficial conversion feature of $1,095 in 2015 and $2,738 in 2014 and net of discount related to warrants of $1,145 in 2015 and $2,863 in 2014 and convertible into common stock at $0.30 per share.) $ 12,760 $ 9,399 $ 12,760 $ 9,399

NOTE 8 - RELATED PARTY TRANSACT

NOTE 8 - RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 8 – RELATED PARTY TRANSACTIONS Common stock issued On April 17, 2015, the board of directors authorized and granted to its executives and board of directors for the year end 2015, restricted common stock bonuses as follows: o Marvin Hausman, CEO, 600,000 shares valued at $120,000, o Devin Andres, COO, 550,000 shares valued at $110,000, o Philip Sobol, board of directors, 200,000 shares valued at $40,000, and o Elliott Shelton, board of directors, 200,000 shares valued at $40,000. Debt agreements from board member as it was insignificant

NOTE 9 - STOCKHOLDERS' EQUITY (

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT)	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock Common stock o 80,000 shares of common stock for conversion of 8,000 shares of Series A preferred stock, o 4,350,000 shares of common stock issued for $435,000 in cash, o 1,550,000 shares of common stock issued to the board of directors and executives valued at $310,000, o 1,900,000 shares of common stock in exchange for conversion of notes payable in the amount of $175,000 plus accrued interest of $12,500, o 2,050,923 shares of common stock in a cashless exchange for 2,158,867 warrants, o 305,165 shares of common stock with a value of $96,732 in exchange for conversion of accounts payable, and o 365,000 shares of common stock with a value of $78,913 for services rendered. o 151,126 shares of common stock with a value of $32,520 upon conversion of $30,000 of convertible notes payable along with accrued interest of $2,520, o 23,000 shares of common stock with a value of $13,113 for services rendered, o 441,620 shares of common stock in exchange for 44,162 shares of Series A preferred stock, and o 80,000 shares of common stock with a value of $46,400 for the settlement of accounts payable in the amount of $149,421. We posted a gain on settlement in the amount of $103,021. o 28,000 shares of common stock for a value of $10,383 for services rendered, o 430,000 shares of common stock issued for $85,005 in cash, o 846,382 shares of common stock in exchange for conversion of notes payable in the amount of $67,500 plus accrued interest of $1,720, and o 55,500 shares with a value of $11,100 in exchange for conversion of accounts payable. o 64,700 shares of common stock for a value of $39,556 for services rendered, o 79,293 shares of common stock for a value of $44,250 for services to be performed in the future, and o 6,717 shares of common stock with a value of $4,501 for the settlement of accounts payable. Stock incentive plan Weighted Weighted Average Average Remaining Aggregate Number of Exercise Price Exercise Contractual Term Intrinsic Shares Range Price (Years) Value Outstanding, December 31, 2013 2,352,099 $ 0.38 - $1.00 $ 0.51 7.90 199,505 Exercisable, December 31, 2013 1,810,344 $ 0.38 - $1.00 $ 0.52 7.88 138,707 Granted 624,571 $ 0.40-$0.75 $ 0.52 6.49 - Exercised - - $ - - - Expired/Forfeited 110,200 $ 0.40-$0.50 $ 0.48 9.51 - Outstanding, December 31, 2014 2,866,470 $ 0.30 - $1.00 $ 0.48 8.96 - Exercisable, December 31, 2014 2,321,001 $ 0.38 - $1.00 $ 0.47 9.50 - Granted 30,000 $ 0.20 $ 0.20 5.00 - Exercised - - $ - - - Expired/Forfeited - - $ - - - Outstanding, June 30, 2015 2,896,470 $ .0.20 - $1.00 $ 0.46 11.24 - Exercisable, June 30, 2015 2,613,354 $ 0.20 - $1.00 $ 0.45 11.74 - Number of Exercise shares Price 190,000 $ 0.20 300,000 $ 0.30 55,000 $ 0.38 1,186,670 $ 0.40 10,000 $ 0.45 631,800 $ 0.50 160,000 $ 0.60 15,000 $ 0.62 100,000 $ 0.75 10,000 $ 0.81 200,000 $ 0.85 38,000 $ 1.00 2,896,470 At June 30, 2015, the Company had 1,803,530 unissued shares available under the Plan. Also, at June 30, 2015, the Company had $140,114 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 11 years. Warrants – Consulting Agreements Date of Issue June 30, 2015 Exercise Price Expiration June-15 302,500 $ 0.125 - $0.15 06/2018 May-15 6,160,000 $ 0.125 - $0.23 05/2018 - 05/2022 April-15 6,160,000 $ 0.01 - $0.15 04/2018 - 04/2027 March-15 140,000 $ 0.10 - $0.75 03/2018 - 03/2022 February-15 - $ 0.00 - January-15 70,000 $ 0.30 - $0.50 01/2020 As of December 2014 7,247,982 $ 0.36 - $10.00 05/2015 - 10/2024 Total 20,080,482 Less: Expired 130,608 Exercised 2,158,867 Total 17,791,007 We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions: June 30, 2015 December 31, 2014 Risk-Free interest rate 0.28% - 1.72 % 0.28% - 2.97 % Expected dividend yield 0 % 0 % Volatility 166.10% - 204.66 % 182.81% - 222.30 % Expected life 3 - 7 years 3 - 10 years At June 30, 2015 and December 31, 2014, the weighted-average Black-Scholes value of warrants granted was $0.14 and $0.39, respectively. On May 20 2015, the board of directors agreed to extend the warrants and options of all employees and the board of directors by 5 years from original date and to reduce the exercise price to $0.40, if favorable to holder. We calculated a loss on modification of the warrants and options of $56,543 and have posted this expense during the quarter. In addition, on May 20, 2015, the Company agreed to extend the outstanding options of a consultant for 5 years and reduce their exercise price to $0.20. We have calculated a loss on the modification in the amount of $4,524 and have posted this expense during the quarter.

NOTE 10 - COMMITMENTS AND CONTI

NOTE 10 - COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 10 – COMMITMENTS AND CONTINGENCIES Leases On April 4, 2012, the Company entered into a Commercial Lease agreement with Lanz Properties, LLC for 13,081 square feet of office and warehouse space located at 13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, OR 97140. The new lease commenced on June 1, 2012 and will terminate on July 31, 2015. No rent was payable until October 2012. The base monthly rental rate started at $3,160, increasing to $3,260 in October 2013, and then $3,343 in June 2014. The Company has straight-lined the full value of the lease agreement over the life of the lease and has recorded this amount monthly. The amount of rent expense that is above the actual rent amount is recorded as deferred rent and is shown on the balance sheet in current liabilities as part of accounts payable and accrued expenses. The amount recorded for as of June 30, 2015 and 2014 is $0 and $5,406, respectively. On May 8, 2015, the Company entered into a lease addendum with Lanz Properties, LLC to extend their lease term for an additional 3 years. The new lease terms maintain the current base monthly rental rate from August 1, 2015 of $3,343 per month increasing to $3,410 in August 2016 and then $3,478 in August 2017. All other provisions of the lease remain. The Company has analyzed the requirement to straight-line the full value of the lease agreement over the life of the lease and has determined that there is no need to book a deferred rent amount on the balance sheet as the amount is immaterial.

NOTE 11 - SUBSEQUENT EVENTS

NOTE 11 - SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 11 – SUBSEQUENT EVENTS

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation and principles of consolidation
Use of Estimates, Policy [Policy Text Block]	Use of estimates
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash
Receivables, Policy [Policy Text Block]	Accounts receivable
Inventory, Policy [Policy Text Block]	Inventory
Property, Plant and Equipment, Policy [Policy Text Block]	Property and equipment Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Patents
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long-lived assets
Debt, Policy [Policy Text Block]	Discount on convertible notes payable
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair value of financial instruments
Fair Value Measurement, Policy [Policy Text Block]	Fair value measurements Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.
Revenue Recognition, Policy [Policy Text Block]	Revenue recognition We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and handling costs
Advertising Costs, Policy [Policy Text Block]	Advertising and promotion costs
Stockholders' Equity, Policy [Policy Text Block]	Equity instruments issued to parties other than employees for acquiring goods or services The assumptions used to determine the fair value of our warrants are as follows: - The expected life of warrants issued represents the period of time the warrants are expected to be outstanding. - The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant. - The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant. - The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.
Income Tax, Policy [Policy Text Block]	Income taxes
Earnings Per Share, Policy [Policy Text Block]	Net loss per common share For the Three Months Ended June 30, For the Six Months Ended June 30, 2015 2014 2015 2014 Numerator: Net loss $ (1,069,336 ) $ (510,763 ) $ (1,589,844 ) $ (1,046,151 ) Denominator: Weighted-average common shares outstanding 23,319,184 8,532,935 19,814,557 8,429,958 Basic and diluted net loss per share $ (0.05 ) $ (0.06 ) $ (0.08 ) $ (0.12 ) Common stock warrants 17,791,007 4,520,308 17,791,007 4,520,308 Series A convertible preferred stock 1,928,070 2,378,070 1,928,070 2,378,070 Stock options 2,896,470 2,572,099 2,896,470 2,572,099 Convertible debt including interest 95,438 900,321 95,438 900,321 Excluded dilutive securities 22,710,985 10,370,798 22,710,985 10,370,798
Reclassification, Policy [Policy Text Block]	Reclassifications
Segment Reporting, Policy [Policy Text Block]	Segments
New Accounting Pronouncements, Policy [Policy Text Block]	Recently issued accounting pronouncements

NOTE 2 - SUMMARY OF SIGNIFICA19

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2015
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table presents a reconciliation of basic loss per share and excluded dilutive securities: For the Three Months Ended June 30, For the Six Months Ended June 30, 2015 2014 2015 2014 Numerator: Net loss $ (1,069,336 ) $ (510,763 ) $ (1,589,844 ) $ (1,046,151 ) Denominator: Weighted-average common shares outstanding 23,319,184 8,532,935 19,814,557 8,429,958 Basic and diluted net loss per share $ (0.05 ) $ (0.06 ) $ (0.08 ) $ (0.12 ) Common stock warrants 17,791,007 4,520,308 17,791,007 4,520,308 Series A convertible preferred stock 1,928,070 2,378,070 1,928,070 2,378,070 Stock options 2,896,470 2,572,099 2,896,470 2,572,099 Convertible debt including interest 95,438 900,321 95,438 900,321 Excluded dilutive securities 22,710,985 10,370,798 22,710,985 10,370,798
Estimated Useful Lives [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) [Line Items]
Property, Plant and Equipment [Table Text Block]	Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets: Office equipment 3 years Production equipment 5 to 7 years Equipment under capital lease 5 to 7 years Leasehold improvements Lesser of lease term or useful life of improvement

NOTE 3 - INVENTORY (Tables)

NOTE 3 - INVENTORY (Tables)	6 Months Ended
	Jun. 30, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory consists of the following at: June 30, 2015 December 31, 2014 Raw materials $ 36,932 $ 202,591 Finished goods 237,819 43,849 274,751 246,440 Less: reserve for excess and obsolete inventory (151,064 ) (151,064 ) $ 123,687 $ 95,376

NOTE 4 - PROPERTY AND EQUIPME21

NOTE 4 - PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment Table [Member]
NOTE 4 - PROPERTY AND EQUIPMENT (Tables) [Line Items]
Property, Plant and Equipment [Table Text Block]	Property and equipment, stated at cost, consists of the following at: June 30, 2015 December 31, 2014 Office equipment $ 30,006 $ 27,507 Production equipment 90,899 86,999 Leasehold improvements 16,328 16,328 137,233 130,834 Less: accumulated depreciation (98,454 ) (87,687 ) $ 38,779 $ 43,147

NOTE 5 - PATENTS AND LICENSES22

NOTE 5 - PATENTS AND LICENSES, NET (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	The gross carrying amounts and accumulated amortization related to these intangible assets consist of the following at: June 30, 2015 December 31, 2014 Licenses and amortizable patents $ 207,244 $ 207,244 Unamortized patents 175,130 166,159 Accumulated amortization (37,309 ) (30,569 ) Patents and Licenses, net $ 345,065 $ 342,834

NOTE 6 - ACCRUED EXPENSES (Tabl

NOTE 6 - ACCRUED EXPENSES (Tables)	6 Months Ended
	Jun. 30, 2015
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued expenses (included with accounts payable) consists of the following at: June 30, 2015 December 31, 2014 Executive compensation $ 320,522 $ 153,432 Other accruals 45,951 19,725 $ 366,473 $ 173,157

NOTE 7 - NOTES PAYABLE (Tables)

NOTE 7 - NOTES PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Notes payable consists of the following: June 30, 2015 December 31, 2014 Notes payable - current 7.85% unsecured, $473 due monthly $ - $ 2,304 7.85% unsecured, $314 due monthly 2,125 - 4.15% unsecured, $3,436 due monthly 6,837 23,726 10.00% unsecured, interest only, due on demand. Note was settled on May 29, 2015 in exchange for 250,000 shares of common stock. In addition, 500,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. We calculated and posted a loss on the settlement in the amount of $32,500. - 25,000 $ 8,962 $ 51,030
Convertible Debt [Table Text Block]	Convertible notes payable, net 8% secured due on December 26, 2015 (net of discount related to beneficial conversion feature of $3,521 in 2015 and $7,746 in 2014), convertible into preferred stock at $5.00 per share. $ 46,479 $ 42,254 6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000 50,000 10% unsecured due March 2015 (net of discount related to warrants of $0 in 2015 and $2,362 in 2014). Note and accrued interest were converted on May 7, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 22,638 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $9,800 in 2014). Note and accrued interest were converted on April 30, 2015 for 1,100,000 shares of common stock. In addition, 2,200,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 90,200 10% unsecured due April 2015 (net of discount related to warrants of $0 in 2015 and $1,377 in 2014). Paid in full in April 2015. - 8,623 8% unsecured due April 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $11,968 in 2014), This note was converted into 527,911 shares of common stock during first quarter 2015 - 30,532 8% unsecured due May 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $19,190 in 2014), $25,000 of this note was converted into 318,471 shares of common stock while the remaining $28,000 was repaid in cash during first quarter 2015. - 33,810 10% unsecured due December 2015 (net of discount related to warrants of $660 and $4,620 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 29,340 25,380 10% unsecured due December 2015 (net of discount related to warrants of $432 in 2015 and $1,727 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 9,568 8,273 10% unsecured due October 2015 (net of discount related to warrants of $665 in 2015 and $1,805 in 2014) convertible price to be determined by the purchase price paid by investors in the Series B, not to exceed $1.50 per share 9,335 8,195 10% unsecured due October 2015 (net of discount related to warrants of $0 in 2015 and $4,512 in 2014) Note and accrued interest were converted on May 21, 2015 for 275,000 shares of common stock. In addition, 550,000 3-year warrants were granted and vested with an exercise price ranging from $0.125 - $0.15. - 20,488 8% unsecured due September 2015 (net of discount related to beneficial conversion feature of $0 in 2015 and $36,247 in 2014). This note was paid off during quarter ended June 30, 2015 - 17,253 $ 144,722 $ 357,646 Convertible notes payable, net related party 0% unsecured due November 2015 (net of discount related to beneficial conversion feature of $1,095 in 2015 and $2,738 in 2014 and net of discount related to warrants of $1,145 in 2015 and $2,863 in 2014 and convertible into common stock at $0.30 per share.) $ 12,760 $ 9,399 $ 12,760 $ 9,399

NOTE 9 - STOCKHOLDERS' EQUITY25

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of option activity under the stock option plan as of June 30, 2015 and changes during the quarter then ended is presented below: Weighted Weighted Average Average Remaining Aggregate Number of Exercise Price Exercise Contractual Term Intrinsic Shares Range Price (Years) Value Outstanding, December 31, 2013 2,352,099 $ 0.38 - $1.00 $ 0.51 7.90 199,505 Exercisable, December 31, 2013 1,810,344 $ 0.38 - $1.00 $ 0.52 7.88 138,707 Granted 624,571 $ 0.40-$0.75 $ 0.52 6.49 - Exercised - - $ - - - Expired/Forfeited 110,200 $ 0.40-$0.50 $ 0.48 9.51 - Outstanding, December 31, 2014 2,866,470 $ 0.30 - $1.00 $ 0.48 8.96 - Exercisable, December 31, 2014 2,321,001 $ 0.38 - $1.00 $ 0.47 9.50 - Granted 30,000 $ 0.20 $ 0.20 5.00 - Exercised - - $ - - - Expired/Forfeited - - $ - - - Outstanding, June 30, 2015 2,896,470 $ .0.20 - $1.00 $ 0.46 11.24 - Exercisable, June 30, 2015 2,613,354 $ 0.20 - $1.00 $ 0.45 11.74 -
Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Table Text Block]	The range of exercise prices for options outstanding under the 2010 Stock Incentive Plan at June 30, 2015 are as follows: Number of Exercise shares Price 190,000 $ 0.20 300,000 $ 0.30 55,000 $ 0.38 1,186,670 $ 0.40 10,000 $ 0.45 631,800 $ 0.50 160,000 $ 0.60 15,000 $ 0.62 100,000 $ 0.75 10,000 $ 0.81 200,000 $ 0.85 38,000 $ 1.00 2,896,470
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Outstanding warrants to purchase common stock are as follows: Date of Issue June 30, 2015 Exercise Price Expiration June-15 302,500 $ 0.125 - $0.15 06/2018 May-15 6,160,000 $ 0.125 - $0.23 05/2018 - 05/2022 April-15 6,160,000 $ 0.01 - $0.15 04/2018 - 04/2027 March-15 140,000 $ 0.10 - $0.75 03/2018 - 03/2022 February-15 - $ 0.00 - January-15 70,000 $ 0.30 - $0.50 01/2020 As of December 2014 7,247,982 $ 0.36 - $10.00 05/2015 - 10/2024 Total 20,080,482 Less: Expired 130,608 Exercised 2,158,867 Total 17,791,007
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions: June 30, 2015 December 31, 2014 Risk-Free interest rate 0.28% - 1.72 % 0.28% - 2.97 % Expected dividend yield 0 % 0 % Volatility 166.10% - 204.66 % 182.81% - 222.30 % Expected life 3 - 7 years 3 - 10 years

NOTE 1 - ORGANIZATION AND OPE26

NOTE 1 - ORGANIZATION AND OPERATIONS (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Disclosure Text Block [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 182,029	$ 99,462	$ 15,484	$ 36,886

NOTE 2 - SUMMARY OF SIGNIFICA27

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	6 Months Ended
	Jun. 30, 2015USD ($)	Dec. 31, 2014USD ($)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Allowance for Doubtful Accounts Receivable (in Dollars)	$ 5,736	$ 30,022
Number of Operating Segments	1
Domestic Patents [Member] | Minimum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years
Domestic Patents [Member] | Maximum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Foreign Patents [Member] | Minimum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Foreign Patents [Member] | Maximum [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years

NOTE 2 - SUMMARY OF SIGNIFICA28

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Property, Plant and Equipment, Estimated Useful Lives	6 Months Ended
	Jun. 30, 2015
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvements	Lesser of lease term or useful life of improvement
Minimum [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Minimum [Member] | Assets Held under Capital Leases [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Maximum [Member] | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years
Maximum [Member] | Assets Held under Capital Leases [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	7 years

NOTE 2 - SUMMARY OF SIGNIFICA29

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Numerator:
Net loss (in Dollars)	$ (1,069,336)	$ (510,763)	$ (1,589,844)	$ (1,046,151)
Denominator:
Weighted-average common shares outstanding	23,319,184	8,532,935	19,814,557	8,429,958
Basic and diluted net loss per share (in Dollars per share)	$ (0.05)	$ (0.06)	$ (0.08)	$ (0.12)
Excluded dilutive securties	22,710,985	10,370,798	22,710,985	10,370,798
Warrant [Member]
Denominator:
Excluded dilutive securties	17,791,007	4,520,308	17,791,007	4,520,308
Convertble Preferred Shares [Member]
Denominator:
Excluded dilutive securties	1,928,070	2,378,070	1,928,070	2,378,070
Equity Option [Member]
Denominator:
Excluded dilutive securties	2,896,470	2,572,099	2,896,470	2,572,099
Convertible Debt Securities [Member]
Denominator:
Excluded dilutive securties	95,438	900,321	95,438	900,321

NOTE 3 - INVENTORY (Details) -

NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Schedule of Inventory [Abstract]
Raw materials	$ 36,932	$ 202,591
Finished goods	237,819	43,849
	274,751	246,440
Less: reserve for excess and obsolete inventory	(151,064)	(151,064)
	$ 123,687	$ 95,376

NOTE 4 - PROPERTY AND EQUIPME31

NOTE 4 - PROPERTY AND EQUIPMENT (Details) - Schedule of Property, Plant and Equipment - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 137,233	$ 130,834
Less: accumulated depreciation	(98,454)	(87,687)
	38,779	43,147
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	30,006	27,507
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	90,899	86,999
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 16,328	$ 16,328

NOTE 5 - PATENTS AND LICENSES32

NOTE 5 - PATENTS AND LICENSES, NET (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
NOTE 5 - PATENTS AND LICENSES, NET (Details) [Line Items]
Amortization of Intangible Assets	$ 3,370	$ 3,849	$ 6,740	$ 7,699
Licensing Agreements [Member]
NOTE 5 - PATENTS AND LICENSES, NET (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life			17 years

NOTE 5 - PATENTS AND LICENSES33

NOTE 5 - PATENTS AND LICENSES, NET (Details) - Schedule of Finite-Lived Intangible Assets - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	$ (37,309)	$ (30,569)
Patents and Licenses, net	345,065	342,834
Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Intangilble assets, gross	207,244	207,244
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangilble assets, gross	$ 175,130	$ 166,159

NOTE 6 - ACCRUED EXPENSES (Deta

NOTE 6 - ACCRUED EXPENSES (Details) - Schedule of Accrued Liabilities - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Schedule of Accrued Liabilities [Abstract]
Executive compensation	$ 320,522	$ 153,432
Other accruals	45,951	19,725
	$ 366,473	$ 173,157

NOTE 7 - NOTES PAYABLE (Details

NOTE 7 - NOTES PAYABLE (Details) - USD ($)	Mar. 11, 2015	Mar. 25, 2014	Mar. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)				20,080,482	7,247,982
Line of Credit [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 60,000
Line of Credit, Current				$ 0
Line of Credit [Member] | Prime Rate [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		3.00%
Notes Payable, Other Payables [Member]
NOTE 7 - NOTES PAYABLE (Details) [Line Items]
Debt Instrument, Face Amount	$ 50,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument, Maturity Date	May 15, 2015
Debt Instrument, Unamortized Discount	$ 3,000
Warrants, Term of Warrants	3 years
Class of Warrant or Rights, Granted (in Shares)	50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.10
Warrants, Fair Value of Warrants, Granted	$ 6,850
Interest Expense, Debt			$ 6,850

NOTE 7 - NOTES PAYABLE (Detai36

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Notes payable - current
Notes payable	$ 8,962	$ 51,030
Note Payable 1 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	0	2,304
Note Payable 2 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	2,125	0
Note Payable 3 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	6,837	23,726
Note Payable 4 [Member] | Loans Payable [Member]
Notes payable - current
Notes payable	$ 0	$ 25,000

NOTE 7 - NOTES PAYABLE (Detai37

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants granted (in Shares)			20,080,482		7,247,982
Note, loss on settlement (in Dollars)	$ 32,500	$ 0	$ 32,500	$ 0
Note Payable 1 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	7.85%		7.85%		7.85%
Due monthly (in Dollars)			$ 473		$ 473
Note Payable 2 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	7.85%		7.85%		7.85%
Due monthly (in Dollars)			$ 314		$ 314
Note Payable 3 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	4.15%		4.15%		4.15%
Due monthly (in Dollars)			$ 3,436		$ 3,436
Note Payable 4 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
%	10.00%		10.00%		10.00%
Due			Due on demand		Due on demand
Note settled in exchange for common stock (in Shares)			250,000
Warrants granted (in Shares)			500,000
Note, loss on settlement (in Dollars)			$ 32,500
Warrants			3 years
Minimum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)					$ 0.36
Minimum [Member] | Note Payable 4 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.125		$ 0.125
Maximum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)					$ 10
Maximum [Member] | Note Payable 4 [Member] | Loans Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.15		$ 0.15

NOTE 7 - NOTES PAYABLE (Detai38

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt - USD ($)	Jun. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	$ 144,722	$ 357,646
Convertible Note Payable, Related Party	12,760	9,399
Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	46,479	42,254
Convertible Note 2 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	50,000	50,000
Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	22,638
Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	90,200
Convertible Note 5 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	8,623
Convertible Note 6 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	30,532
Convertible Note 7 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	33,810
Convertible Note 8 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	29,340	25,380
Convertible Note 9 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	9,568	8,273
Convertible Note 10 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	9,335	8,195
Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	20,488
Convertible Note 12 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable	0	17,253
Related Party Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt [Line Items]
Convertible Note Payable, Related Party	$ 12,760	$ 9,399

NOTE 7 - NOTES PAYABLE (Detai39

NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants granted (in Shares)	20,080,482	7,247,982
Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Due on	Dec. 26, 2015	Dec. 26, 2015
Discount related to beneficial conversion feature	$ 3,521	$ 7,746
Convertible at (in Dollars per share)	$ 5	$ 5
Convertible Note 2 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	6.00%	6.00%
Convertible at (in Dollars per share)	$ 2	$ 2
Due	Due on demand	Due on demand
Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	March 2,015	March 2,015
Discount related to warrants	$ 0	$ 2,362
Converted to common stock (in Shares)	275,000
Warrants granted (in Shares)	550,000
Warrants	3 years
Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	April 2,015	April 2,015
Discount related to warrants	$ 0	$ 9,800
Converted to common stock (in Shares)	1,100,000
Warrants granted (in Shares)	2,200,000
Warrants	3 years
Convertible Note 5 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	April 2,015	April 2,015
Discount related to warrants	$ 0	$ 1,377
Convertible Note 6 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 11,968
Due	April 2,015	April 2,015
Converted to common stock (in Shares)	527,911
Convertible Note 7 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 19,190
Due	May 2,015	May 2,015
Converted to common stock (in Shares)	318,471
Note converted	$ 25,000
Note repaid in cash	$ 28,000
Convertible Note 8 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	December 2,015	December 2,015
Discount related to warrants	$ 660	$ 4,620
Convertible Note 9 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	December 2,015	December 2,015
Discount related to warrants	$ 432	$ 1,727
Convertible Note 10 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	October 2,015	October 2,015
Discount related to warrants	$ 665	$ 1,805
Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	10.00%	10.00%
Due	October 2,015	October 2,015
Discount related to warrants	$ 0	$ 4,512
Converted to common stock (in Shares)	275,000
Warrants granted (in Shares)	550,000
Warrants	3 years
Convertible Note 12 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	8.00%	8.00%
Discount related to beneficial conversion feature	$ 0	$ 36,247
Due	September 2,015	September 2,015
Related Party Convertible Note 1 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
%	0.00%	0.00%
Discount related to beneficial conversion feature	$ 1,095	$ 2,738
Convertible at (in Dollars per share)	$ 0.30	$ 0.30
Due	November 2,015	November 2,015
Discount related to warrants	$ 1,145	$ 2,863
Minimum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)		$ 0.36
Minimum [Member] | Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.125
Minimum [Member] | Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.125
Minimum [Member] | Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.125
Maximum [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)		$ 10
Maximum [Member] | Convertible Note 3 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.15
Maximum [Member] | Convertible Note 4 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	0.15
Maximum [Member] | Convertible Note 11 [Member] | Convertible Notes Payable [Member]
NOTE 7 - NOTES PAYABLE (Details) - Schedule of Convertible Debt (Parentheticals) [Line Items]
Warrants, exercise price (in Dollars per share)	$ 0.15

NOTE 8 - RELATED PARTY TRANSA40

NOTE 8 - RELATED PARTY TRANSACTIONS (Details) - USD ($)	Apr. 17, 2015	Jul. 01, 2014	Dec. 31, 2014	Jun. 30, 2015	Dec. 31, 2014
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Class of Warrant or Rights, Granted (in Shares)				20,080,482	7,247,982
Chief Executive Officer [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	600,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 120,000
Chief Operating Officer [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	550,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 110,000
Director [Member] | Convertible Debt [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		0.00%
Debt Instrument, Face Amount		$ 15,000
Warrants, Term of Warrants		5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		15,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.50
Warrants, Fair Value of Warrants, Granted		$ 5,445
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 0.50
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 7,545
Director [Member] | Note Extension [Member] | Convertible Debt [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)			$ 0.20		$ 0.20
Warrants, Fair Value of Warrants, Granted			$ 3,435
Debt Instrument, Convertible, Conversion Price (in Dollars per share)			$ 0.30		$ 0.30
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 3,285
Class of Warrant or Rights, Granted (in Shares)			15,000
Debt Instrument, Difference in Fair Value Related to Modification			$ 27
Director [Member] | Issuance to Director #1 [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	200,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 40,000
Director [Member] | Issucance to Director #2 [Member]
NOTE 8 - RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)	200,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 40,000

NOTE 9 - STOCKHOLDERS' EQUITY41

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - USD ($)	May. 20, 2015	May. 26, 2011	Sep. 17, 2010	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Preferred Stock, Shares Authorized				5,000,000				5,000,000		5,000,000
Class of Warrant or Rights, Exercised								2,158,867
Gains (Losses) on Restructuring of Debt (in Dollars)				$ 0		$ 103,021		$ 0	$ 103,021
Warrants, Grants in Period, Weighted-Average Grant Date Fair Value (in Dollars per share)								$ 0.14		$ 0.39
2010 Stock Incentive Plan [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			4,650,000
Share-based Compensation Arrangement by Share-based Payment Award, Description			an annual increase in shares of 50,000 as of January 1 of each year; commencing January 1, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				1,803,530				1,803,530
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)				$ 140,114				$ 140,114
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition								11 years
Stock Issued for Cash [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, New Issues				4,350,000	430,000
Stock Issued During Period, Value, New Issues (in Dollars)				$ 435,000	$ 85,005
Stock Issued for Services Rendered [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross				1,550,000
Stock Issued During Period, Value, Share-based Compensation, Gross (in Dollars)				$ 310,000
Stock Issued During Period, Shares, Issued for Services				365,000	28,000	23,000	64,700
Stock Issued During Period, Value, Issued for Services (in Dollars)				$ 78,913	$ 10,383	$ 13,113	$ 39,556
Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				1,900,000	846,382	151,126
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)						$ 32,520
Conversion of Warrants [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				2,050,923
Class of Warrant or Rights, Exercised				2,158,867
Conversion of Accounts Payable [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				305,165	55,500	80,000	6,717
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 96,732	$ 11,100	$ 46,400	$ 4,501
Debt Conversion, Original Debt, Amount (in Dollars)						$ 149,421
Stock Issued for Future Services [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services							79,293
Stock Issued During Period, Value, Issued for Services (in Dollars)							$ 44,250
Options Granted for Non-Employee Services [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Warrants, Term of Warrants	5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.20
Derivative, Gain (Loss) on Derivative, Net (in Dollars)	$ (4,524)
Series A Preferred Stock [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Preferred Stock, Shares Authorized		350,000		350,000				350,000		350,000
Preferred Stock, No Par Value (in Dollars per share)		$ 0.001
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)		$ 5
Preferred Stock, Conversion Basis		one-for-ten
Conversion of Stock, Shares Converted				8,000		44,162
Conversion of Stock, Shares Issued				80,000		441,620
Series A Preferred Stock [Member] | Convertble Preferred Shares [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities				80,000		441,620
Principal [Member] | Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 175,000		$ 30,000
Debt Conversion, Original Debt, Amount (in Dollars)					67,500
Interest [Member] | Covnersion of Convertible Notes Payable and Acrrued Interest [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities (in Dollars)				$ 12,500		$ 2,520
Debt Conversion, Original Debt, Amount (in Dollars)					$ 1,720
Employees [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) [Line Items]
Warrants, Term of Warrants	5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.40
Derivative, Gain (Loss) on Derivative, Net (in Dollars)	$ (56,543)

NOTE 9 - STOCKHOLDERS' EQUITY42

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Number of Shares (in Shares)	2,896,470	2,866,470	2,352,099
Options Outstanding, Weighted Average Exercise Price	$ 0.46	$ 0.48	$ 0.51
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	11 years 87 days	8 years 350 days	7 years 328 days
Options Outstanding, Aggregate Intrinsic Value (in Dollars)	$ 0	$ 0	$ 199,505
Options Exercisable, Number of Shares (in Shares)	2,613,354	2,321,001	1,810,344
Options Exercisable, Weighted Average Exercise Price	$ 0.45	$ 0.47	$ 0.52
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	11 years 270 days	9 years 6 months	7 years 321 days
Options Exercisable, Aggregate Intrinsic Value (in Dollars)	$ 0	$ 0	$ 138,707
Options Granted, Number of Shares (in Shares)	30,000	624,571
Options Granted, Exercise Price	$ 0.20
Options Granted, Weighted Average Exercise Price	$ 0.20	$ 0.52
Options Granted, Weighted Average Remaining Contractual Term	5 years	6 years 178 days
Options Exercised, Number of Shares (in Shares)	0	0
Options Exercised, Weighted Average Exercise Price	$ 0	$ 0
Options Expired, Number of Shares (in Shares)	0	110,200
Options Expired, Weighted Average Exercise Price	$ 0	$ 0.48
Options Expired, Weighted Average Remaining Contractual Term		9 years 186 days
Minimum [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Exercise Price	0.20	$ 0.30	$ 0.38
Options Exercisable, Exercise Price	0.20	0.38	0.38
Options Granted, Exercise Price		0.40
Options Expired, Exercise Price		0.40
Maximum [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Stock Options, Activity [Line Items]
Options Outstanding, Exercise Price	1	1	1
Options Exercisable, Exercise Price	$ 1	1	$ 1
Options Granted, Exercise Price		0.75
Options Expired, Exercise Price		$ 0.50

NOTE 9 - STOCKHOLDERS' EQUITY43

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range - $ / shares	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	2,896,470	2,866,470	2,352,099
Options Exercisable at $0.20 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	190,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.20
Options Exercisable at $0.30 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	300,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.30
Options Exercisable at $0.38 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	55,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.38
Options Exercisable at $0.40 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	1,186,670
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.40
Options Exercisable at $0.45 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	10,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.45
Options Exercisable at $0.50 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	631,800
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.50
Options Exercisable at $0.60 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	160,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.60
Options Exercisable at $0.62 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	15,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.62
Options Exercisable at $0.75 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	100,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.75
Options Exercisable at $0.81 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	10,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.81
Options Exercisable at $0.85 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	200,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 0.85
Options Exercisable at $1.00 [Member]
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Share-based Compensation, Shares Outstanding under Stock Option Plans, by Exercise Price Range [Line Items]
Number of Options Outstanding	38,000
Exercise Price of Options Outstanding (in Dollars per share)	$ 1

NOTE 9 - STOCKHOLDERS' EQUITY44

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Schedule of Stockholders' Equity Note, Warrants - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	20,080,482	7,247,982
Warrants Expiration		05/2015 - 10/2024
Less:
Expired (in Shares)	130,608
Exercised (in Shares)	2,158,867
Total (in Shares)	17,791,007
Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	302,500
Warrants Expiration	06/2018
Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	6,160,000
Warrants Expiration	05/2018 - 05/2022
Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	6,160,000
Warrants Expiration	04/2018 - 04/2027
Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	140,000
Warrants Expiration	03/2018 - 03/2022
Warrants Issued February 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	0
Warrants Exercise Price	$ 0
Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in Shares)	70,000
Warrants Expiration	01/2020
Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price		$ 0.36
Minimum [Member] | Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	$ 0.125
Minimum [Member] | Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.125
Minimum [Member] | Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.01
Minimum [Member] | Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.10
Minimum [Member] | Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.30
Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price		$ 10
Maximum [Member] | Warrants Issued June 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.15
Maximum [Member] | Warrants Issued May 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.23
Maximum [Member] | Warrants Issued April 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.15
Maximum [Member] | Warrants Issued March 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	0.75
Maximum [Member] | Warrants Issued January 2015 [Member]
Class of Warrant or Right [Line Items]
Warrants Exercise Price	$ 0.50

NOTE 9 - STOCKHOLDERS' EQUITY45

NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Fair Value Measurements, Warrants, Valuation Assumptions	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-Free interest rate	0.28%	0.28%
Volatility	166.10%	182.81%
Expected life	3 years	3 years
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-Free interest rate	1.72%	2.97%
Volatility	204.66%	222.30%
Expected life	7 years	10 years

NOTE 10 - COMMITMENTS AND CON46

NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) - Land and Building [Member]	May. 08, 2015USD ($)	Apr. 04, 2012USD ($)ft²	Jun. 30, 2014USD ($)	Oct. 31, 2013USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Area of Real Estate Property (in Square Feet) | ft²		13,081
Operating Leases, Rent Expense, Minimum Rentals		$ 3,160	$ 3,343	$ 3,260
Operating Leases, Rent Expense, Net					$ 0	$ 5,406
Lessee Leasing Arrangements, Operating Leases, Term of Contract	3 years
Operating Lease, Monthly Rental Expense, Year 1 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	$ 3,343
Operating Lease, Monthly Rental Expense, Year 2 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	3,410
Operating Lease, Monthly Rental Expense, Year 3 [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details) [Line Items]
Operating Leases, Rent Expense, Minimum Rentals	$ 3,478

NOTE 11 - SUBSEQUENT EVENTS (De

NOTE 11 - SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 29, 2015	Jul. 27, 2015	Jul. 31, 2015	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Class of Warrant or Rights, Granted				20,080,482		7,247,982
Proceeds from Issuance or Sale of Equity (in Dollars)				$ 0	$ 40,000
Subsequent Event [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		322,500
Class of Warrant or Rights, Granted		645,000	800,000
Warrants, Term of Warrants		3 years
Stock Issued During Period, Shares, New Issues			400,000
Proceeds from Issuance or Sale of Equity (in Dollars)			$ 40,000
Stock Issued During Period, Shares, Issued for Services	15,000	100,000
Stock Issued During Period, Value, Issued for Services (in Dollars)	$ 2,550	$ 18,000
Principal [Member] | Subsequent Event [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Debt Conversion, Original Debt, Amount (in Dollars)		30,000
Interest [Member] | Subsequent Event [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Debt Conversion, Original Debt, Amount (in Dollars)		$ 2,500
Minimum [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)						$ 0.36
Minimum [Member] | Subsequent Event [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.125
Maximum [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)						$ 10
Maximum [Member] | Subsequent Event [Member]
NOTE 11 - SUBSEQUENT EVENTS (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.15